All Publications

Alshaker, H., Wang, Q., Srivats, S., Chao, Y., Cooper, C., Pchejetski, D.

(2017)

New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth,

in Breast Cancer Research and Treatment

165

(3)

pp. 531–543

Full Text UEA Repository

(Article)

(Published)


Wang, Q., Alshaker, H., Böhler, T., Srivats, S., Chao, Y., Cooper, C., Pchejetski, D.

(2017)

Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer,

in Scientific Reports

7

article no. 5901

Full Text UEA Repository

(Article)

(Published)


Alshaker, H., Wang, Q., Böhler, T., Mills, R., Winkler, M., Arafat, T., Kawano, Y., Pchejetski, D.

(2017)

Combination of RAD001 (everolimus) and docetaxel reduces prostate and breast cancer cell VEGF production and tumour vascularisation independently of sphingosine-kinase-1,

in Scientific Reports

7

article no. 3493

Full Text UEA Repository

(Article)

(Published)


Pchejetski, D., Kenbaz, M., Alshaker, H., Rajput, D., Jesudason, K.

(2017)

An unusual case of disseminated intravascular coagulation,

in Oxford Medical Case Reports

2017

(4)

article no. omx009

Full Text UEA Repository

(Article)

(Published)


Alshaker, H., Wang, Q., Kawano, Y., Arafat, T., Böhler, T., Winkler, M., Cooper, C., Pchejetski, D.

(2016)

Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1,

in Oncotarget

7

(49)

pp. 80943-80956

Full Text UEA Repository

(Article)

(Published)


Sacco, K., Muhammad, A., Saleem, W., Alshaker, H., Monzon, L., Islam, M. R., Pchejetski, D.

(2016)

Leptomeningeal carcinomatosis as the primary presentation of relapse in breast cancer,

in Oncology Letters

12

(2)

pp. 779-782

Full Text

(Literature review)

(Published)


White, C., Alshaker, H., Cooper, C., Winkler, M., Pchejetski, D.

(2016)

The emerging role of FTY720 (Fingolimod) in cancer treatment,

in Oncotarget

7

(17)

pp. 23106-23127

Full Text

(Literature review)

(Published)


Alshaker, H., Sacco, K., Alfraidi, A., Muhammad, A., Winkler, M., Pchejetski, D.

(2015)

Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemma,

in Oncotarget

6

(34)

pp. 35556-35563

Full Text UEA Repository

(Article)

(Published)


Alshaker, H., Wang, Q., Frampton, A. E., Krell, J., Waxman, J., Winkler, M., Stebbing, J., Cooper, C., Yaguee, E., Pchejetski, D.

(2015)

Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer,

in Breast Cancer Research and Treatment

149

(1)

pp. 59-67

Full Text UEA Repository

(Article)

(Published)


Alshaker, H., Krell, J., Frampton, A. E., Wang, Q., Cooper, C., Winkler, M., Yaguee, E., Pchejetski, D., Alshaker, H.

(2015)

Leptin receptor-dependent and -independent STAT3 phosphorylation in oestrogen receptor-negative breast cancer,

in International Journal of Molecular Medicine

36

pp. S6

(Abstract)

(Published)


Alshaker, H., Krell, J., Frampton, A. E., Waxman, J., Blyuss, O., Zaikin, A., Winkler, M., Stebbing, J., Yaguee, E., Pchejetski, D.

(2014)

Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway,

in Breast Cancer Research

16

article no. 426

Full Text UEA Repository

(Article)

(Published)


Pshezhetskiy, D., Alshaker, H., Stebbing, J.

(2014)

Castrate-resistant prostate cancer: the future of antiandrogens,

in Trends in Urology & Men’s Health

5

(1)

Full Text

(Editorial)

(Published)


Pinho, F. G., Frampton, A. E., Nunes, J., Krell, J., Alshaker, H., Jacob, J., Pellegrino, L., Roca-Alonso, L., de Giorgio, A., Harding, V., Waxman, J., Stebbing, J., Pchejetski, D., Castellano, L.

(2013)

Downregulation of microRNA-515-5p by the Estrogen Receptor Modulates Sphingosine Kinase 1 and Breast Cancer Cell Proliferation,

in Cancer Research

73

(19)

pp. 5936-5948

Full Text UEA Repository

(Article)

(Published)


Alshaker, H., Sauer, L., Monteil, D., Ottaviani, S., Srivats, S., Böhler, T., Pchejetski, D.

(2013)

Chapter Six – Therapeutic Potential of Targeting SK1 in Human Cancers,

in Advances in Cancer Research : The Role of Sphingolipids in Cancer Development and Therapy.

Elsevier

pp. 143-200

ISBN 978-0-12-394274-6

Full Text

(Chapter (peer-reviewed))

(Published)